The 'QALY' shouldn't be used in drug cost-effectiveness reviews - STAT

The 'QALY' shouldn't be used in drug cost-effectiveness reviews - STAT

The U.S. shouldn’t use the ‘QALY’ in drug cost-effectiveness reviews

By WILLIAM S. SMITH

ADOBE

The QALY, aka the quality-adjusted life year, assigns a subjective value to a year of perfect health. That's a problem for drug cost-effectiveness reviews.

READ MORE